Weill Cornell Medicine researchers have identified a brain circuit linked to anxiety that may provide a new drug target, ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

Human-first precision health Pharmaphorum asked Charlie Kim, head of molecular science at Verily (which takes a “human-first precision approach to drug target discovery”), to expand on the ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has recently announced the breakthrough study achieved in collaboration with a ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

The potential of AI-powered drug discovery is huge ... AI’s real power lies in that critical first phase: zeroing in on targets that might’ve otherwise slipped through the cracks, saving ...

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and effective drugs.

The VisionCyte platform leverages high resolution morphological profiling, high-throughput capabilities, and advanced AI ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...